Orexo AB (ORX.ST) - Not Halal (Non-Compliant)
Orexo AB (ORX.ST) is classified as Not Halal (Non-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Result
- Pass
- Reason
- The sector "Healthcare" and industry "Drug Manufacturers - Specialty & Generic" are not in the excluded categories.
Financial Ratios
- Debt Ratio
- Value: N/A | Threshold: 30% | Result: Warning
- Cash & Interest-bearing Securities Ratio
- Value: N/A | Threshold: 30% | Result: Warning
- Non-Permissible Income Ratio
- Value: 15.8% | Threshold: 5% | Result: Fail
Dividend Purification
Purification percentage: 15.77%.Based on the company's financial statements, approximately 15.77% of dividend income comes from non-permissible sources; this is the share many investors donate to purify it. This is derived from identified interest income (15.77% of total income). Some scholars may differ on the exact calculation method.
About Orexo AB
Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; Edluar for the treatment of insomnia; and Diabact UBT for the treatment of diagnosis of Helicobacter pylori. The company is developing Izipry for opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; OX390 for overdoses caused by a combination of life-threatening illicit drugs; OX125 for opioid overdose with powder-based nalmefene; OX472 for intranasal formulation of semaglutide, a GLP-1 receptor agonist, developed using proprietary AmorphOX technology; and develops thermostable and needle-free mucosal vaccines. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.
Frequently Asked Questions
Is Orexo AB (ORX.ST) stock halal to invest in?
According to AAOIFI Shariah screening standards, Orexo AB (ORX.ST) is currently classified as Not Halal (Non-Compliant). This is based on both business activity and financial ratio screening.


